Using MC1R Genotype to Impact Melanoma Risk Behavior
NCT03509467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2054
Last updated 2025-12-19
Summary
The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.
Conditions
- Melanoma (Skin)
- Squamous Cell Carcinoma
- Squamous Cell Cancer
- Skin Cancer
- Basal Cell Carcinoma
- Basal Cell Cancer
Interventions
- BEHAVIORAL
-
Personalized Information
Personalized information about ways that participants can protect themselves and their child from developing melanoma.
- BEHAVIORAL
-
Standard Information
Standard information about ways that participants can protect themselves and their child from developing melanoma.
- OTHER
-
DNA Extraction Determination of MC1R Genotypes
After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.
Sponsors & Collaborators
-
Ponce Health Sciences University
collaborator OTHER -
University of South Florida
collaborator OTHER -
American Cancer Society, Inc.
collaborator OTHER -
H. Lee Moffitt Cancer Center and Research Institute
lead OTHER
Principal Investigators
-
Peter Kanetsky, Ph.D · H. Lee Moffitt Cancer Center and Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-03
- Primary Completion
- 2021-02-19
- Completion
- 2021-02-19
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511 ·Status: RECRUITING
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
A Study of Risk Factors for the COVID-19 Virus Infection
NCT04697927 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
Genetic Susceptibility to Lung Cancer in Never Smokers
NCT00597636 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Exploring Men s Prostate Cancer Genetic Risk Perceptions
NCT06764992 ·Status: COMPLETED
-
Study of Hair Samples From Patients With Cancer
NCT00899691 ·Status: COMPLETED
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma
NCT01143311 ·Status: TERMINATED ·Phase: NA
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Natural History Study of Moles and Suspicious Melanoma
NCT00288938 ·Status: COMPLETED
-
Skin Cancer Screening Education Study
NCT02352428 ·Status: UNKNOWN ·Phase: NA
-
Pathogenic Variants in Genes Associated With Lung Adenocarcinoma
NCT06181812 ·Status: RECRUITING
-
MElanoma Research Lymph Node Prediction Implementation National_001
NCT04759781 ·Status: ACTIVE_NOT_RECRUITING
-
REFLECT: Reproductive Education and Fertility Links for Cancer Treatment
NCT06199726 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
NCT00582387 ·Status: COMPLETED
-
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT00369109 ·Status: COMPLETED
-
The Identification of Novel Prognostic Markers in Melanoma
NCT01002560 ·Status: UNKNOWN
-
Biomarkers of Molecular Risk in Smokers
NCT00598143 ·Status: COMPLETED